The Mitochondrial Antioxidant SS-31 Modulates Oxidative Stress, Endoplasmic Reticulum Stress, and Autophagy in Type 2 Diabetes

Mitochondrial dysfunction has been shown to play a central role in the pathophysiology of type 2 diabetes (T2D), and mitochondria-targeted agents such as SS-31 are emerging as a promising strategy for its treatment. We aimed to study the effects of SS-31 on leukocytes from T2D patients by evaluating...

Descripción completa

Detalles Bibliográficos
Autores principales: Escribano-López, Irene, de Marañon, Aranzazu M, Iannantuoni, Francesca, López-Domènech, Sandra, Abad-Jiménez, Zaida, Díaz, Pedro, Solá, Eva, Apostolova, Nadezda, Rocha, Milagros, Víctor, Víctor M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780723/
https://www.ncbi.nlm.nih.gov/pubmed/31466264
http://dx.doi.org/10.3390/jcm8091322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780723/
https://www.ncbi.nlm.nih.gov/pubmed/31466264
http://dx.doi.org/10.3390/jcm8091322

Ejemplares similares